Search Results

There are 14389 results for: content related to: Risk factors of fibrosis in alcohol-induced liver disease

  1. Body Fat Distribution and Risk Factors for Fibrosis in Patients with Alcoholic Liver Disease

    Alcoholism: Clinical and Experimental Research

    Volume 37, Issue 2, February 2013, Pages: 332–338, Sylvie Naveau, Anca-Stela Dobrin, Axel Balian, Micheline Njiké-Nakseu, Pascal Nohra, Amani Asnacios, Sophie Prévot and Gabriel Perlemuter

    Version of Record online : 7 SEP 2012, DOI: 10.1111/j.1530-0277.2012.01927.x

  2. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  3. You have free access to this content
    Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients

    Liver Transplantation

    Volume 21, Issue 11, November 2015, Pages: 1383–1394, Mamatha Bhat, Peter Ghali, Kathleen C. Rollet-Kurhajec, Aparna Bhat, Philip Wong, Marc Deschenes and Giada Sebastiani

    Version of Record online : 17 OCT 2015, DOI: 10.1002/lt.24217

  4. Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 967–978, Cosmin S. Voican, Micheline Njiké-Nakseu, Hédia Boujedidi, Nadège Barri-Ova, Laurence Bouchet-Delbos, Hélène Agostini, Sophie Maitre, Sophie Prévot, Anne-Marie Cassard-Doulcier, Sylvie Naveau and Gabriel Perlemuter

    Version of Record online : 3 JUN 2014, DOI: 10.1111/liv.12575

  5. You have free access to this content
    Poster Session II (Abstracts 730 – 1194)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 361–601,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28798

  6. You have free access to this content
    Poster Session 4: Steatohepatitis: Clinical and Therapeutic

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1252A–1305A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28240

  7. You have free access to this content
    Poster Session I (Abstracts 259 – 729)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 136–361,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28797

  8. How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C?

    Journal of Gastroenterology and Hepatology

    Volume 13, Issue 4, April 1998, Pages: 419–426, MAHBUB H KHAN, LIZA THOMAS, KAREN BYTH, JAMES KENCH, MARTIN WELTMAN, JACOB GEORGE, CHRISTOPHER LIDDLE and GEOFFREY C FARRELL

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1440-1746.1998.tb00657.x

  9. Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease

    Liver International

    Volume 30, Issue 9, October 2010, Pages: 1346–1354, Paul Calès, Jérôme Boursier, Julien Chaigneau, Fabrice Lainé, Jeremy Sandrini, Sophie Michalak, Isabelle Hubert, Nina Dib, Frédéric Oberti, Sandrine Bertrais, Gilles Hunault, Christine Cavaro-Ménard, Yves Gallois, Yves Deugnier and Marie C. Rousselet

    Version of Record online : 23 JUL 2010, DOI: 10.1111/j.1478-3231.2010.02314.x

  10. You have free access to this content
    Poster Session 4: Acute Liver Failure and Artificial Liver Support; Diagnostics, Epidemiology, and Natural History

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1064A–1132A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28236

  11. You have free access to this content
    Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 9, May 2007, Pages: 1047–1054, P. MATHURIN, F. BEUZIN, A. LOUVET, N. CARRIÉ-GANNE, A. BALIAN, J. C. TRINCHET, D. DALSOGLIO, S. PREVOT and S. NAVEAU

    Version of Record online : 22 FEB 2007, DOI: 10.1111/j.1365-2036.2007.03302.x

  12. You have free access to this content
    AASLD Abstracts (pp. 383A–483A)

    Hepatology

    Volume 38, Issue S4, October 2003, Pages: 383A–483A,

    Version of Record online : 10 FEB 2006, DOI: 10.1002/hep.1840380506

  13. Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B

    Hepatology Research

    Volume 43, Issue 6, June 2013, Pages: 596–604, Kenji Ikeda, Namiki Izumi, Eiji Tanaka, Hiroshi Yotsuyanagi, Yoshihisa Takahashi, Junichi Fukushima, Fukuo Kondo, Toshio Fukusato, Kazuhiko Koike, Norio Hayashi and Hiromitsu Kumada

    Version of Record online : 7 NOV 2012, DOI: 10.1111/j.1872-034X.2012.01115.x

  14. Non-invasive fibrosis score for hepatitis delta

    Liver International

    Volume 37, Issue 2, February 2017, Pages: 196–204, Gunnar L. Lutterkort, Anika Wranke, Cihan Yurdaydin, Eva Budde, Max Westphal, Ralf Lichtinghagen, Judith Stift, Birgit Bremer, Svenja Hardtke, Onur Keskin, Ramazan Idilman, Armin Koch, Michael P. Manns, Hans P. Dienes, Heiner Wedemeyer and Benjamin Heidrich

    Version of Record online : 10 AUG 2016, DOI: 10.1111/liv.13205

  15. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease

    Liver International

    Volume 36, Issue 4, April 2016, Pages: 572–579, Mohammad S. Siddiqui, Kavish R. Patidar, Sherry Boyett, Velimir A. Luketic, Puneet Puri and Arun J. Sanyal

    Version of Record online : 24 JAN 2016, DOI: 10.1111/liv.13054

  16. Influence of intestinal flora on the development of fibrosis and cirrhosis in a rat model

    Journal of Gastroenterology and Hepatology

    Volume 15, Issue 11, November 2000, Pages: 1307–1311, John L Plummer, Chris J Ossowicz, Catherine Whibley, Anthony H Ilsley and Pauline De La M Hall

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1440-1746.2000.2340.x

  17. You have free access to this content
    AASLD Abstract (pp. 162A–266A)

    Hepatology

    Volume 40, Issue S4, October 2004, Pages: 162A–266A,

    Version of Record online : 10 FEB 2006, DOI: 10.1002/hep.1840400503

  18. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver

    Journal of Magnetic Resonance Imaging

    Volume 41, Issue 2, February 2015, Pages: 329–338, Masahiro Okada, Takamichi Murakami, Norihisa Yada, Kazushi Numata, Minori Onoda, Tomoko Hyodo, Tatsuo Inoue, Kazunari Ishii and Masatoshi Kudo

    Version of Record online : 17 DEC 2013, DOI: 10.1002/jmri.24529

  19. Oltipraz therapy in patients with liver fibrosis or cirrhosis: a randomized, double-blind, placebo-controlled phase II trial

    Journal of Pharmacy and Pharmacology

    Volume 63, Issue 5, May 2011, Pages: 627–635, Sang Geon Kim, Young Mi Kim, Jong Young Choi, Joon-Yeol Han, Jeong Won Jang, Se-Hyun Cho, Soon Ho Um, Chae Yoon Chon, Dong Hoo Lee, Ja-June Jang, Eunsil Yu and Young Sok Lee

    Version of Record online : 14 MAR 2011, DOI: 10.1111/j.2042-7158.2011.01259.x

  20. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C

    Liver International

    Volume 32, Issue 4, April 2012, Pages: 622–628, Claudia Verveer, Pieter E. Zondervan, Fibo J. W. ten Kate, Bettina E. Hansen, Harry L. A. Janssen and Robert J. de Knegt

    Version of Record online : 17 OCT 2011, DOI: 10.1111/j.1478-3231.2011.02663.x